Active Energy Group (LON: AEG) shares have returned from suspension following publication of interims. Shareholders voted against liquidating the company and Zen Ventures provided a loan of £200,000 to enable the publication of 2023 accounts earlier in December and the subsequent interims have been released. Zen Ventures will appoint two directors. The plan is to commercialise the CoalSwitch technology. The share price has soared 336.4% to 0.24p.
Specialist surface coatings company Hardide (LON: HDD) has signed a ten-year supply agreement with an Aerospace business to coat cargo door components. The customer will fund equipment modifications, and they should be completed by March. There will be initial production volumes generating at least £500,000 in the current financial year. Total revenues from the contract should be more than £6m. The share price jumped 29% to 6.125p.
Oil and gas producer Zephyr Energy (LON: ZPHR) has signed a farm-out agreement for the onshore US State 36-2 LNW-CC-R well in the Paradox Basin in exchange for $7.5m of funding f0r all expected drilling, completion and production test costs. Net revenues will be split 50/50 with a US industry wellbore investor from the start of production. Discussions continue with partners for the development of the rest of the Paradox Basin interests. The share price increased 12.7% to 3.1p.
Wind turbine monitoring technology developer Windar Photonics (LON: WPHO) has won a US order worth $2.5m to be delivered in the first half of 2025. This is the largest order the company has received. The share price improved 9.9% to 55.5p.
CRISM Therapeutics (LON: CRTX) has been granted a European patent for biodegradable chemotherapeutic drug implants comprising irinotecan. It covers the manufacturing process for the implant for treating brain tumours. A clinical trial is planned for 2025. The share price rose 8.33% to 13p.
FALLERS
Retailer Shoe Zone (LON: SHOE) says the recent National Insurance increase have increased costs, and it is closing stores are not considered viable. Consumer confidence is weak. The focus is bigger, more profitable stores. The company has halved its 2024-25 pre-tax profit guidance to net less than £5m. Although profit estimates for the year to September 2024 are unchanged at £9.5m there will be no final dividend. The share price slumped 42.2% to 80p, which is ten times forecast 2024-25 earnings.
In the year to June 2024, Botswana Diamonds (LON: BOD) reports a £417,000 cash outflow from operating activities and a near-halving of exploration spending to £70,000. Since June, £250,000 has been raised to replenish the bank balance. AI analysis of the company’s data bank has enabled the discovery of seven kimberlites and potentially found other minerals. According to chairman John Teeling the diamond industry is splitting into real and lab-grown diamonds sectors, but he is confident of the future of the real diamond. Restarting production at Thorny River depends on higher diamond prices. The share price declined 26.3% to 0.165p.
Provexis (LON: PXS) is purchasing a further batch of Fruitflow heart-health functional food ingredient inventory from dsm-firmnech to satisfy increasing demand for Fruitflow. The royalty based on gross profit will be paid to dsm-firmnech in shares. The total payment for inventory and royalty is 82.95 million shares at 0.68p each. DSM Venturing owns 10.9%. The share price fell 3.21% to 0.6775p.